Cochrane Abstracts
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Palivizumab for Preventing Severe Respiratory Syncytial Virus (RSV) Infection in Children." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433460/all/Interval_debulking_surgery_for_advanced_epithelial_ovarian_cancer:_Cochrane_systematic_review. Accessed 25 April 2024.
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433460/all/Interval_debulking_surgery_for_advanced_epithelial_ovarian_cancer:_Cochrane_systematic_review. Accessed April 25, 2024.
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433460/all/Interval_debulking_surgery_for_advanced_epithelial_ovarian_cancer:_Cochrane_systematic_review
Palivizumab for Preventing Severe Respiratory Syncytial Virus (RSV) Infection in Children [Internet]. In: Cochrane Abstracts. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433460/all/Interval_debulking_surgery_for_advanced_epithelial_ovarian_cancer:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children
ID - 433460
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433460/all/Interval_debulking_surgery_for_advanced_epithelial_ovarian_cancer:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
